Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma Back to media releasesNext media release LONDON, Jan. 7, 2025 /PRNewswire/ —… CISION PRNewswireJanuary 7, 2025
WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager SHANGHAI and SAN DIEGO, Jan. 7, 2025 /PRNewswire/ — WuXi Biologics ("WuXi… CISION PRNewswireJanuary 7, 2025
Press ReleaseLG UNVEILS A DAY IN A LIFE WITH "AFFECTIONATE INTELLIGENCE" AT LG WORLD PREMIERE Company Showcases Future of AI-Powered Customer Experiences Through CEO Keynote and Immersive… CISION PRNewswireJanuary 7, 2025
Press ReleaseMedtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference GALWAY, Ireland, Jan. 7, 2025 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global… CISION PRNewswireJanuary 7, 2025
Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination NEW YORK, Jan. 7, 2025 /PRNewswire/ — Aquaron Acquisition Corp. (NASDAQ: AQU,… CISION PRNewswireJanuary 7, 2025
Blue Owl Capital Hires Algebris Investments' Yoichi Nakamura to Lead Private Wealth in Japan Yoichi brings over two decades of experience covering securities companies and scaling… CISION PRNewswireJanuary 7, 2025
Heidrick & Struggles Announces 2025 Global and Regional Leader Appointments The promotions span across six practice areas and three regions to drive… CISION PRNewswireJanuary 7, 2025
Press ReleaseTechTCL Unveils Next-Gen NXTPAPER 4.0 Display Technology at CES 2025 Adds Advanced TCL NXTPAPER Tablet and Smartphoneto Award-Winning Portfolio LAS VEGAS, Jan.… CISION PRNewswireJanuary 7, 2025
